July 25, 2011
In this week’s installment of highlighting investment opportunities, today, I’m going to cover ImmunoCellular Therapeutics (IMUC). Background ImmunoCellular Therapeutics is a California-based oncology firm with the lead candidate ICT-107 entering Phase II for patients with a particular form of brain cancer, glioblastoma multiforme (GBM). IMUC’s primary candidate targets cancer stem cells via a dendritic cell-based […]
Read the full article →
May 19, 2011
In another installment of highlighting various investment opportunities, today, I’m going to cover CytRx Corporation (ticker: CYTR). As a biotech guy myself, I’m always interested in up and coming biotech outfits. Not only do they often have the potential to jump 100% or more in a single day when a pivotal drug study is released […]
Read the full article →